36 filings
6-K
PPBT
Purple Biotech Ltd
23 Dec 19
Current report (foreign)
4:20pm
6-K
PPBT
Purple Biotech Ltd
19 Nov 19
Report of Foreign Private Issuer
4:31pm
6-K
PPBT
Purple Biotech Ltd
12 Nov 19
Current report (foreign)
4:26pm
6-K
PPBT
Purple Biotech Ltd
18 Oct 19
Thank you Corporate Presentation October 2019
4:09pm
6-K
PPBT
Purple Biotech Ltd
11 Oct 19
Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch of ConsensiTMin the U.S
9:02am
6-K
is0rxyfe9af3o8 34e
2 Oct 19
Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board
8:49am
6-K
v1bhbubu84y9dju
10 Sep 19
Thank you Corporate Presentation September 2019
9:32am
6-K
hus9p tcv
9 Sep 19
Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug Resistance
8:40am
6-K
fbdw66h15fm
3 Sep 19
Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
8:23am
6-K
92er0
29 Aug 19
Report of Foreign Private Issuer
8:30am
6-K
6b87xrcrjor5
20 Aug 19
Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition Deal
6:04am
6-K
guj1jul 8p
14 Aug 19
Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities Authority
12:00am
6-K
qu5rg3bjt2zi
13 Aug 19
Current report (foreign)
5:01pm
6-K
h95 joze2wptskp
8 Aug 19
Kitov Pharma Reports First Half 2019 Financial Results and Provides Business Update
4:32pm
6-K
naorkx1
12 Jul 19
Kitov Receives Nasdaq Notification Regarding Minimum Bid Requirements
5:12pm
6-K
19rup bry21
2 Jul 19
Report of Foreign Private Issuer
4:31pm
6-K
vvvse7f up59tmivt5jp
27 Jun 19
Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancers
7:35am
6-K
ywt43fa 905w
16 May 19
Report of Foreign Private Issuer
7:30am
6-K
82fayowfom
10 May 19
Report of Foreign Private Issuer
4:02pm
6-K
qt985x6lx
9 May 19
Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference
4:05pm